Open an account

Genex Pharmaceutical

GENX · OTC

$0.0001−$0.0001 (−50.00%)TodayMarket closed ·
No price history for this range.

About GENX

Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company is headquartered in Tianjin, Tianjin and currently employs 86 full-time employees. The company went IPO on 2006-05-23. The Company’s main business is engaged in producing and distributing Reconstituted Bone Xenograft (RBX). The RBX is a medical device that accelerates bone healing. The firm distributes its medical devices to hospitals as well as other medical device customers that are not hospitals.

Employees
86
Headquarters
Tianjin, Tianjin
Listed
May 23, 2006
Sector
Health Care
Industry
Health Care Equipment & Supplies

GENX key statistics

Market cap
1.78K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
1.80K
Volume
200
Open price
$0.0001
High today
$0.0001
Low today
$0.0001
52 Week high
$0.0002
52 Week low
$0.0001

Genex Pharmaceutical (GENX) at a glance

As of May 14, 2026, Genex Pharmaceutical (GENX) shares are priced at $0.0001, giving the company a market cap of 1.78K and a price-to-earnings ratio of 0.00.

Volume so far is 200 shares, below the average of 1.80K shares a day.

Over the past year Genex Pharmaceutical has ranged from $0.0001 to $0.0002, and now sits 0% of the way up that range.

Similar companies

Companies in the same industry as Genex Pharmaceutical

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.